IL1B and Alzheimer disease: Independent studies in AD patients by Forlenza et al. and Holmes et al. provided direct evidence that increased plasma levels of IL-1β correlated with higher cognitive decline, thus suggesting the possible progression of AD from systemic inflammatory events [238, 239].